SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004727
Filing Date
2019-05-09
Accepted
2019-05-09 17:01:42
Documents
57
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20190331x10q.htm 10-Q 1458780
2 EX-10.1 xncr-20190331ex1013c2c31.htm EX-10.1 1362480
3 EX-31.1 xncr-20190331ex3112349b9.htm EX-31.1 19397
4 EX-31.2 xncr-20190331ex312595239.htm EX-31.2 19381
5 EX-32.1 xncr-20190331ex321327ecf.htm EX-32.1 10582
  Complete submission text file 0001558370-19-004727.txt   7518249

Data Files

Seq Description Document Type Size
6 EX-101.INS xncr-20190331.xml EX-101.INS 1376453
7 EX-101.SCH xncr-20190331.xsd EX-101.SCH 38374
8 EX-101.CAL xncr-20190331_cal.xml EX-101.CAL 51514
9 EX-101.DEF xncr-20190331_def.xml EX-101.DEF 156394
10 EX-101.LAB xncr-20190331_lab.xml EX-101.LAB 430896
11 EX-101.PRE xncr-20190331_pre.xml EX-101.PRE 301880
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 19811538
SIC: 2834 Pharmaceutical Preparations